Sandra Levy is a reporter specializing in health and healthcare trends. She has held the position of Associate Editor of Healthline Networks’ news division. From 1998 to 2008, Levy was a reporter, and managing Editor-Projects for Drug Topics Magazine, where she covered pharmacy chains and business, self care, over-the-counter medicines, and Rx-to-OTC switches. She also served as Senior Medical Writer for WRS Health, an EMR software company, and co-authored an e-book on hyperparathyroidism. Levy has authored several weekly columns for Gannett Company's Journal News, served as Newsletter Editor for the Rockland Business Association, and as a reporter for The Hudson Valley Business Journal.
The technology, developed by a multi-institutional team led by the Cincinnati Children's Heart Institute, would allow doctors to intervene earlier to help patients manage their conditions and help inform future pharmacologic treatment options.
The researchers’ next goal is to make a more integrated system so that the processing is done on the phone so the user can see the results as soon as testing is done.
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.
The system's estimates of national and regional flu activity had error rates 2- to 3-fold lower than earlier predictive models. It also correctly estimated the timing and magnitude of the national flu peak week.
In the new study, the researchers used a compound that has a very high affinity for tau proteins.
In a newly published study, the researchers reported that their new digital approach yielded more accurate predictions of future arrhythmic events than current blood pumping measurements.
Researchers from the Perelman School of Medicine at the University of Pennsylvania presented their study findings last week at the Heart Rhythm Society’s annual meeting in San Francisco.
The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development.
The app is part of a larger effort in which LeanTaaS taps into non-sensitive electronic health records data, then builds predictive models to forecast usage patterns and allocate OR time efficiently.
Imagine this scenario: A surgeon is set to suture pieces of soft tissue on a patient, but instead of doing the whole procedure by himself, he turns to a surgical robot for assistance.
The Michigan researchers developed a microfluidic device that sandwiches a thin, permeable polyester membrane and a layer of cultured kidney cells between the top and bottom compartments.
If Google is able to overcome the many hurdles to bringing this device to market, it could revolutionize the eye care industry. “What’s in their patent is the Holy Grail for patients over 40 years old," said Dr. Jeffrey Sonsino, an optometrist in Nashville, Tennessee.
In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means.